en | P-Care

1 Obtaining biological samples from patients

Chips of patients' tumors and their surrounding tissues will be recovered during surgery or biopsy and sent to p-care labs, along with patients’ blood samples.

2 Developing avatars

Collected samples will be subject to different procedures in order to develop complex, 3D cell systems (organoids and spheroids) containing different types of cells. Developed systems will imitate the tumor-of-origin and its tissue microenvironment.

3 Studying drug resistance mechanisms

Developed systems will be treated with different drugs used in anti-cancer therapy in order to analyse their response and the contribution of the microenvironment to it. Resistant cells will be identified and characterized by means of various analyses. Data obtained from tumor organoids and spheroids will be used to identify key determinants of drug resistance.

4 Experimenting novel therapeutic strategies

Collections of drugs will be tested on different cell systems in combination with conventional therapies to evaluate drug synergism and effective overcoming of treatment resistance.

5 Generating resources

Biological material, generated tumor- and tissue-like systems, and data will be collected and stored for reuse in research. They will expand the cross-border biobank initiated with a previous interreg project, PreCanMed.

6 Transferring and exchanging knowledge

Training activities and material will be developed in order to make p-care technologies and methods available to biologists, clinical oncologists, bioinformaticians and other professionals in the field of cancer biology and medicine.

10/06/2022

Tumors, Covid and precision medicine

p-care members organize a meeting with the public to discuss precision cancer medicine and the impact of Covid on cancer care.

10/06/2022

                    
                        Discuss technologic aspects of models of precision cancer medicine and stay at the forefront of cancer research!

Researchers discuss technological aspects of their experimental work with colleagues to accelerate scientific progress together. As second highlight a panel of leading scientist discuss their cutting edge cancer research in expert's seminars.

10/06/2022

Unravelling pathways that control immortalization using tumor organoids

p-care partner Stefan Schoeftner and his team at the University of Trieste publish a scientific article involving the use of tumor-organoids to provide insights into mechanisms of cancer cell immortalization (Nature Communications)